FMC
Desconocido
CONVINCE: The Comparison of High Dose Heamodiafiltration HDF versus Haemodialyse
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
participó en un
H2020:
H2020-SC1-2016-2017
End stage kidney disease ranks among the most severe chronic non-communicable diseases with an unmet medical need, given the high (between 1...
2017-12-05 - 2023-12-31 | Financiado
2017-12-05 - 2023-12-31 | Financiado
CaReSyAn: Combatting the CardioRenal Syndrome towards an integrative Analysis to reduce cardiovascular burden...
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
participó en un
H2020:
H2020-MSCA-ITN-2017
Successfully combatting a complex disease requires multi-disciplinary and methodically well-trained scientists. CaReSyAn strives to accompli...
2017-08-10 - 2021-12-31 | Financiado
2017-08-10 - 2021-12-31 | Financiado
* No se disponen de datos de la empresa actual.